![]()
李乾斌
— 博士生导师
分享到：
-
教师姓名：李乾斌
-
职称：教授
-
职务：博士生导师
-
教师拼音名称：liqianbin
-
所在单位：湘雅药学院
-
学历：博士研究生毕业
-
入职时间：2010-04-22
-
学位：博士学位
-
毕业院校：山东大学
-
在职信息：在职
-
学科：药学
-
招生学科：药学
- He Y., Le X., Hu G., Li Q., Chen Z. Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer. Pharmaceuticals (Basel), 2023, 16(2).
- Hu L., Sun C., Kidd J.M., Han J., Fang X., Li H., Liu Q., May A.E., Li Q., Zhou L., Liu Q. A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi. Nat Commun, 2023, 14(1): 2745.
- Li H., Hu L., Cuffee C.W., Mohamed M., Li Q., Liu Q., Zhou L., Liu Q. Correction: Interdomain interactions dictate the function of the Candida albicans Hsp110 protein Msi3. J. Biol. Chem., 2023, 299(2): 102879.
- Liu R., Chen Z., Hu G., Yu Z., Li Q., Liu D., Li L., Liu Z. A Novel PDK1/MEK Dual Inhibitor Induces Cytoprotective Autophagy via the PDK1/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Pharmaceuticals (Basel), 2023, 16(2).
- Ma B., Cao Y., Qin J., Chen Z., Hu G., Li Q. Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension. Drug Discov Today, 2023, 28(5): 103559.
- Qin J., Cao M., Hu X., Tan W., Ma B., Cao Y., Chen Z., Li Q., Hu G. Dual inhibitors of ASK1 and PDK1 kinases: Design, synthesis, molecular docking and mechanism studies of N-benzyl pyridine-2-one containing derivatives as anti-fibrotic agents. Eur J Med Chem, 2023, 247: 115057.
- Wu S., Xiao Z., Wei J., Zhang L., Cao Y., Chen Z., Li Q., Hu G. Imidazo[1,2-a]pyridine Derivatives as AMPK Activators: Synthesis, Structure-Activity Relationships, and Regulation of Reactive Oxygen Species in Renal Fibroblasts. ChemMedChem, 2023, 18(8): e202200696.
- Zhao C., Le X., Li M., Hu Y., Li X., Chen Z., Hu G., Hu L., Li Q. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model. Respir. Res., 2023, 24(1): 289.
- Chen Q., Le X., Li Q., Liu S., Chen Z. Exploration of inhibitors targeting KIF18A with ploidy-specific lethality. Drug Discov Today, 2024, 29(10): 104142.
- Hu X., Wu Y., Ouyang H., Wu J., Yao M., Chen Z., Li Q. Virtual Screening, Molecular Dynamics, and Mechanism Study of Homeodomain-Interacting Protein Kinase 2 Inhibitor in Renal Fibroblasts. Pharmaceuticals (Basel), 2024, 17(11): 1420.
教师个人主页
中南大学
访问量：次
返回首页